Should stroke be considered both a brain attack and a heart attack?

Stroke

Volumn 38, Issue 6, 2007, Pages 1713-1714

  Chaturvedi, Seemant ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Cardiac disease; Statins

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; CORONARY RISK; EDITORIAL; HEALTH CARE POLICY; HEART INFARCTION; HEART PROTECTION; HUMAN; MEDICAL LITERATURE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; RISK FACTOR; SCREENING; STROKE; VASCULAR SURGERY;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 34249777821     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.487223     Document Type: Editorial

References (9)

1. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486-2497.
2. Grundy SM, Cleeman JI, Merz CNB, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; for the Coordinating Committee of the National Cholesterol Education Program, Endorsed by the National Heart L, and Blood Institute, American College of Cardiology Foundation, and American Heart Association. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation. 2004;110:227-239.
3. Dhamoon M, Tai W, Boden-Albala B, Runek T, Paik MC, Sacco RL, Elkind MSV. Risk of myocardial infarction or vascular death after first ischemic stroke: The Northern Manhattan study. Stroke. 2007;38:1752-1758.
4. Adams RJ, Chimowitz MI, Alpert JS, Awad IA, Cerqueria MD, Fayad P, Taubert KA; American Heart Association/American Stroke Association. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Stroke. 2003;34:2310-2322.
5. Joseph LN, Babikian VL, Allen NC, Winter MR. Risk factor modification in stroke prevention: the experience of a stroke clinic. Stroke. 1999;30:16-20.
6. Ovbiagele B, Saver JL, Bang H, Chambless LE, Nassief A, Minuk J, Toole JF, Crouse JR; for the VISP Study Investigators. Statin treatment and adherence to national cholesterol guidelines after ischemic stroke. Neurology. 2006;66:1164-1170.
7. Betancourt M, Van Stavern RB, Share D, Gardella P, Martus M, Chaturvedi S. Are patients receiving maximal medical therapy following carotid endarterectomy? Neurology. 2004;63:2011-2015.
8. Mangano DT, Layug EL, Wallace A, Tateo I; The Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med. 1996;335:1713-1721.
9. Kennedy J, Quan H, Buchan AM, Ghali WA, Feasby TE. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke. 2005;36:2072-2076.